Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02006394 · ClinicalTrials.gov registry record · NA
Novel Dietary Interventions for Treating Insulin Resistance
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT02006394 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 41 participants.
The verdict
NCT02006394, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
Clinical and rodent studies have demonstrated the impact of specific dietary factors in modulating inflammation-related diseases including insulin resistance, type 2 diabetes, and cardiovascular disease. Such dietary factors include polyunsaturated fats, polyphenols, and glycemic index. The investigators know from previous studies in the literature that reducing the glycemic index and increasing the omega-3 fat and polyphenol content of the diet results in improved metabolic indices and reduced inflammation. These improvements can be observed even within the context of persistent obesity. The investigators will implement a reduced-calorie, multi-pronged dietary approach for improving insulin sensitivity and reducing inflammation in obese subjects with the metabolic syndrome. The active diet will include reduced glycemic index foods together with omega-3 fats and polyphenol supplements. The primary hypothesis is that the dietary combination of reduced glycemic index foods, omega-3 fats and polyphenols will work to reduce insulin resistance and inflammation more efficiently than a placebo-controlled, calorie- and macronutrient-matched diet in obese subjects with the metabolic syndrome.
Interventions
- DIETARY_SUPPLEMENT Fish Oil
- DIETARY_SUPPLEMENT Polyphenol Capsules
- DIETARY_SUPPLEMENT Corn Oil Capsules
- DIETARY_SUPPLEMENT Corn starch capsules
- OTHER Reduced glycemic index bread products
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2012-01 |
| Est. Completion | 2013-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02006394
The ClinicalTrials.gov registry entry for NCT02006394 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Fish Oil is the first listed.
NCT02006394 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02006394 about?
NCT02006394 is a clinical study titled "Novel Dietary Interventions for Treating Insulin Resistance". Clinical and rodent studies have demonstrated the impact of specific dietary factors in modulating inflammation-related diseases including insulin resistance, type 2 diabetes, and cardiovascular disease. Such dietary factors include polyunsaturated fats, polyphenols, and glycemic index. The investig...
What is the current status of trial NCT02006394?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2012-01. Estimated completion is 2013-11.
What interventions are being tested in trial NCT02006394?
The interventions under investigation include: Fish Oil (DIETARY_SUPPLEMENT), Polyphenol Capsules (DIETARY_SUPPLEMENT), Corn Oil Capsules (DIETARY_SUPPLEMENT), Corn starch capsules (DIETARY_SUPPLEMENT), Reduced glycemic index bread products (OTHER).
Who is sponsoring clinical trial NCT02006394?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.